NCT03717129View on ClinicalTrials.gov

Analysis of Crushed and Whole Tablet Genvoya

PHASE4CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

Genvoya Oral dose

Single Genvoya oral dose directly observed

DRUG

Genvoya Crushed Dose

Single Genvoya crushed tablet in water directly observed

Trial Locations (1)

21205

Johns Hopkins University, Baltimore

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT03717129 - Analysis of Crushed and Whole Tablet Genvoya | Biotech Hunter | Biotech Hunter